Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

New developments in molecular imaging

ESMO 2012

28 Sep - 2 Oct 2012

Published: 5 Oct 2012

Views: 3157

Rating:

Save

Prof Wim Oyen – Radboud University Nijmagen Medical Centre, Netherlands

Prof Wim Oyen talks to ecancer about a joint symposium between the European Association of Nuclear Medicine and ESMO on molecular imaging at the 2012 ESMO meeting in Vienna.

Filming supported by Amgen

Related Videos

SABCS 2023: Latest breast cancer diagnostics guidelines

Prof Nadia Harbeck and Prof Giuseppe Curigliano

SABCS 2023: Latest breast cancer diagnostics guidelines ( Prof Nadia Harbeck and Prof Giuseppe Curigliano )

Genomic testing: Awareness and effective communication between healthcare...

Prof Richard Simcock and Antonella Cardone

Genomic testing: Awareness and effective communication between healthcare professionals and patients ( Prof Richard Simcock and Antonella Cardone )

Community-based breast cancer control programme in the Philipines

Kara Magsanoc-Alikpala - ICanServe Foundation, Manila, Philippines

Community-based breast cancer control programme in the Philipines ( Kara Magsanoc-Alikpala - ICanServe Foundation, Manila, Philippines )

Initiatives for cancer control in Indonesia

Dr K Kardinah - National Cancer Center/Dharmais Cancer Hospital, Jakarta...

Initiatives for cancer control in Indonesia ( Dr K Kardinah - National Cancer Center/Dharmais Cancer Hospital, Jakarta, Indonesia )

War in Ukraine: The Global Medical Knowledge Alliance's response to improving...

Prof Richard Sullivan, Asst. Prof Darya Kizub and Asst. Prof Nelya Melnitchouk

War in Ukraine: The Global Medical Knowledge Alliance's response to improving cancer care ( Prof Richard Sullivan, Asst. Prof Darya Kizub and Asst. Prof Nelya Melnitchouk )

Liquid biopsies and cancer: The role of NGS, CTC, exosomes, cfDNA and cfRNA

Dr Bruna Pellini - Moffitt Cancer Center, Tampa, USA

Liquid biopsies and cancer: The role of NGS, CTC, exosomes, cfDNA and cfRNA ( Dr Bruna Pellini - Moffitt Cancer Center, Tampa, USA )

Choosing Wisely in radiology Tanzania

Dr Revelian Iramu - Ocean Road Cancer Institute, Dar es Salaam, Tanzania

Choosing Wisely in radiology Tanzania ( Dr Revelian Iramu - Ocean Road Cancer Institute, Dar es Salaam, Tanzania )

Why tumour markers are not recommended as screening tests

Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines

Why tumour markers are not recommended as screening tests ( Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines )

HER2DX confirms the ability of the test to predict long-term survival and...

Prof Aleix Prat - Hospital Clínic Barcelona, Barcelona, Spain

HER2DX confirms the ability of the test to predict long-term survival and response to anti-HER2 therapy in BC ( Prof Aleix Prat - Hospital Clínic Barcelona, Barcelona, Spain )

More from ecancer